Description
This compound may exhibit anti-angiogenic and anticancer benefit through the potential inhibition of VEGFR2 (Flk-1), Met, RET, Axl, Ron, PDGFR, FGFR1 (Flg), and FMS-related tyrosine kinases 1, 3, and 4 (FLT1/3/4).
>
产品中心 >
clinical_research >
LKT/4,4U2032-(1,1U2032-BIPHENYL-4,4U2032-DIYLDIOXY)DIANILINE/B3472/25 g
This compound may exhibit anti-angiogenic and anticancer benefit through the potential inhibition of VEGFR2 (Flk-1), Met, RET, Axl, Ron, PDGFR, FGFR1 (Flg), and FMS-related tyrosine kinases 1, 3, and 4 (FLT1/3/4).
Cas No. | 13080-85-8 |
---|---|
Purity | ≥98% |
Formula | C24H20N2O2 |
Formula Wt. | 368.43 |
IUPAC Name | 4-[4-[4-(4-aminophenoxy)phenyl]phenoxy]aniline |
Synonym | 4,4’-Bis(4-aminophenoxy)biphenyl |
Appearance | White to off white powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
Info Sheet | B3472 Info Sheet PDF |
---|